BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 11837721)

  • 1. Efficacy of early immunosuppressive therapy in a child with carbamazepine-associated vanishing bile duct and Stevens-Johnson syndromes.
    Garcia M; Mhanna MJ; Chung-Park MJ; Davis PH; Srivastava MD
    Dig Dis Sci; 2002 Jan; 47(1):177-82. PubMed ID: 11837721
    [No Abstract]   [Full Text] [Related]  

  • 2. Vanishing bile duct and Stevens-Johnson syndrome associated with ciprofloxacin treated with tacrolimus.
    Okan G; Yaylaci S; Peker O; Kaymakoglu S; Saruc M
    World J Gastroenterol; 2008 Aug; 14(29):4697-700. PubMed ID: 18698687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-associated acute-onset vanishing bile duct and Stevens-Johnson syndromes in a child.
    Srivastava M; Perez-Atayde A; Jonas MM
    Gastroenterology; 1998 Sep; 115(3):743-6. PubMed ID: 9721172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute vanishing bile duct syndrome after ibuprofen therapy in a child.
    Taghian M; Tran TA; Bresson-Hadni S; Menget A; Felix S; Jacquemin E
    J Pediatr; 2004 Aug; 145(2):273-6. PubMed ID: 15289784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vanishing bile duct syndrome associated with azithromycin in a 62-year-old man.
    Juricic D; Hrstic I; Radic D; Skegro M; Coric M; Vucelic B; Francetic I
    Basic Clin Pharmacol Toxicol; 2010 Jan; 106(1):62-5. PubMed ID: 19906050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vanishing bile duct syndrome in a child with toxic epidermal necrolysis: an interplay of unbalanced immune regulatory mechanisms.
    Karnsakul W; Arkachaisri T; Atisook K; Wisuthsarewong W; Sattawatthamrong Y; Aanpreung P
    Ann Hepatol; 2006; 5(2):116-9. PubMed ID: 16807519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic cholestasis, paucity of bile ducts, red cell aplasia, and the Stevens-Johnson syndrome. An ampicillin-associated case.
    Cavanzo FJ; Garcia CF; Botero RC
    Gastroenterology; 1990 Sep; 99(3):854-6. PubMed ID: 2116345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbamazepine-induced Stevens-Johnson syndrome treated with IV steroids and IVIG.
    Straussberg R; Harel L; Ben-Amitai D; Cohen D; Amir J
    Pediatr Neurol; 2000 Mar; 22(3):231-3. PubMed ID: 10734256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vanishing bile duct syndrome and inflammatory pseudotumor associated with a case of anabolic steroid abuse.
    Capra F; Nicolini N; Morana G; Guglielmi A; Capelli P; Vantini I
    Dig Dis Sci; 2005 Aug; 50(8):1535-7. PubMed ID: 16110850
    [No Abstract]   [Full Text] [Related]  

  • 10. Education and imaging. Hepatology: Rare Stevens-Johnson syndrome and vanishing bile duct syndrome induced by acetaminophen, requiring liver transplantation.
    Harimoto N; Wang H; Ikegami T; Takeishi K; Itoh S; Yamashita YI; Yoshizumi T; Aishima S; Shirabe K; Oda Y; Maehara Y
    J Gastroenterol Hepatol; 2015 Apr; 30(4):656. PubMed ID: 25776963
    [No Abstract]   [Full Text] [Related]  

  • 11. Ursodeoxycholic acid treatment of vanishing bile duct syndromes.
    Pusl T; Beuers U
    World J Gastroenterol; 2006 Jun; 12(22):3487-95. PubMed ID: 16773706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cytomegalovirus hepatitis and ductopenia in a heart transplant recipient].
    Pérez Calle JL; Salcedo M; Núñez O; Barrio J; Bañares R; de Diego A; Alvarez E; Palomo J; Clemente G
    Gastroenterol Hepatol; 2003 Jan; 26(1):26-8. PubMed ID: 12525325
    [No Abstract]   [Full Text] [Related]  

  • 13. Stevens-Johnson syndrome in neuroleptic-carbamazepine combination.
    Wong KE
    Singapore Med J; 1990 Oct; 31(5):432-3. PubMed ID: 1979691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug-induced vanishing-bile-duct syndrome].
    Suto T; Miyazawa J; Watanabe Y
    Ryoikibetsu Shokogun Shirizu; 1995; (8):59-62. PubMed ID: 8581721
    [No Abstract]   [Full Text] [Related]  

  • 15. Toxic epidermal necrolysis and cyclosporin.
    Jarrett P; Ha T; Snow J
    Clin Exp Dermatol; 1997 Sep; 22(5):254. PubMed ID: 9536553
    [No Abstract]   [Full Text] [Related]  

  • 16. Reversible vanishing bile duct syndrome induced by carbamazepine.
    Ramos AM; Gayotto LC; Clemente CM; Mello ES; Luz KG; Freitas ML
    Eur J Gastroenterol Hepatol; 2002 Sep; 14(9):1019-22. PubMed ID: 12352223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vanishing bile duct syndrome occurring after carbamazepine administration: a second case report.
    de Galoscy C; Horsmans Y; Rahier J; Geubel AP
    J Clin Gastroenterol; 1994 Oct; 19(3):269-71. PubMed ID: 7806846
    [No Abstract]   [Full Text] [Related]  

  • 18. Carbamazepine-induced Stevens-Johnson syndrome in a child.
    Keating A; Blahunka P
    Ann Pharmacother; 1995 May; 29(5):538-9. PubMed ID: 7655141
    [No Abstract]   [Full Text] [Related]  

  • 19. Mycophenolate mofetil for drug-induced vanishing bile duct syndrome.
    Jakab SS; West AB; Meighan DM; Brown RS; Hale WB
    World J Gastroenterol; 2007 Dec; 13(45):6087-9. PubMed ID: 18023105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of vanishing bile duct syndrome with hyperlipidemia.
    Yamauchi R; Takata K; Fukunaga A; Tanaka T; Yokoyama K; Shakado S; Nabeshima K; Yoshimitsu K; Hirai F
    Clin J Gastroenterol; 2022 Aug; 15(4):784-790. PubMed ID: 35802301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.